Global law firm White & Case LLP has advised Nordic Capital on its acquisition of Evosep, a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics.
As part of the transaction, minority shareholders EIFO and Novo Holdings will divest their respective shareholdings, while Evosep founders Ole Vorm and Matthias Mann will remain invested in the company.
Founded in 2016, Evosep has developed a technology that enables fast, robust and high-throughput protein analysis. It develops cutting edge instruments and consumables for reproducible liquid chromatography-mass spectrometry (LC-MS)-based proteomics workflows, driving efficiency and scalability for translational research and biopharma applications.
Nordic Capital is a leading sector-specialised private equity investor. Since its inception in 1989, it has invested €34 billion in nearly 150 investments.
The White & Case team was led by partners Tony Brown (London) and Stefan Koch (Frankfurt) and included partners Michael Engel, Jessica Kemp, Martin Forbes (all London), Orion Berg (Paris), Michael Bark-Jones (Stockholm), David Bond (Washington, DC) and Tamer Nagy (Washington, DC & Cairo) and associates Brad Cope, Alex Ward, Harry White, Kike Lawal, Alice Parsons (all London), Joao Lacerda (London & Brussels), Alexander Berlin-Jarhamn (Stockholm), Allison Kepkay and Gabriela Baca (both Washington, DC).
Press contact
For more information please speak to your local media contact.
Read the orginal article: https://www.whitecase.com/news/press-release/white-case-advises-nordic-capital-acquisition-evosep
